Page last updated: 2024-11-08

pentylenetetrazole and Myocardial Infarction

pentylenetetrazole has been researched along with Myocardial Infarction in 2 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WOLLHEIM, E1
SASAMOTO, H1
Fink, M1
Abrams, R1

Other Studies

2 other studies available for pentylenetetrazole and Myocardial Infarction

ArticleYear
[CARDIAC AND VASCULAR INSUFFICIENCY AND THEIR TREATMENT].
    Nihon Ishikai zasshi. Journal of the Japan Medical Association, 1963, Nov-01, Volume: 50

    Topics: Angiotensins; Blood Pressure; Blood Volume; Cardiovascular Diseases; Digitalis; Digitalis Glycosides

1963
Answers to questions frequently asked about ECT.
    Seminars in psychiatry, 1972, Volume: 4, Issue:1

    Topics: Age Factors; Anesthesia, Intravenous; Brain Damage, Chronic; Brain Neoplasms; Depression; Electrocon

1972